Federated Hermes Inc. trimmed its stake in Colgate-Palmolive Company (NYSE:CL – Free Report) by 6.7% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 435,553 shares of the company’s stock after selling 31,342 shares during the quarter. Federated Hermes Inc. owned approximately 0.05% of Colgate-Palmolive worth $34,818,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently made changes to their positions in CL. Westside Investment Management Inc. lifted its stake in Colgate-Palmolive by 85.5% in the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after acquiring an additional 130 shares during the last quarter. Vermillion & White Wealth Management Group LLC boosted its position in Colgate-Palmolive by 86.1% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after purchasing an additional 155 shares during the period. Copia Wealth Management acquired a new position in Colgate-Palmolive in the 3rd quarter valued at about $29,000. MTM Investment Management LLC bought a new position in Colgate-Palmolive in the 2nd quarter valued at about $39,000. Finally, Twin Peaks Wealth Advisors LLC acquired a new stake in Colgate-Palmolive during the second quarter worth approximately $44,000. Institutional investors own 80.41% of the company’s stock.
Wall Street Analyst Weigh In
CL has been the topic of several research reports. Bank of America decreased their target price on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, January 21st. Morgan Stanley dropped their target price on Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating for the company in a report on Monday, November 3rd. Evercore ISI decreased their price target on shares of Colgate-Palmolive from $100.00 to $94.00 and set an “outperform” rating on the stock in a research note on Monday, November 3rd. Finally, Argus reiterated a “hold” rating on shares of Colgate-Palmolive in a research note on Thursday, December 11th. Eleven analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $90.13.
Colgate-Palmolive Stock Performance
Shares of Colgate-Palmolive stock opened at $90.28 on Friday. The company has a current ratio of 0.93, a quick ratio of 0.60 and a debt-to-equity ratio of 5.90. The company has a market cap of $72.77 billion, a PE ratio of 25.29, a price-to-earnings-growth ratio of 5.74 and a beta of 0.30. The company has a 50 day moving average of $80.77 and a 200-day moving average of $81.43. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $100.18.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a net margin of 14.47% and a return on equity of 333.39%. The business had revenue of $5.23 billion for the quarter, compared to analysts’ expectations of $5.13 billion. During the same period last year, the firm posted $0.91 earnings per share. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. As a group, equities research analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 58.26%.
Colgate-Palmolive News Summary
Here are the key news stories impacting Colgate-Palmolive this week:
- Positive Sentiment: Q4 results beat Street estimates — EPS of $0.95 vs. $0.91 expected and revenue above consensus; management cited strong pricing and brand leadership as drivers of performance. Colgate Q4 Earnings Top Estimates, Strong Pricing Drives Results
- Positive Sentiment: Management issued FY‑2026 revenue guidance that’s above consensus (guidance range provided), signaling confidence in sustained demand for essentials across key regions — a primary catalyst for the stock rally. Colgate-Palmolive forecasts upbeat annual sales as essentials spending holds firm
- Positive Sentiment: Core categories showed resilience — oral care and pet nutrition strength plus a Latin America rebound helped sales growth; Market commentary highlights this operating improvement as a near-term positive for margins and top-line momentum. Colgate-Palmolive’s Core Strength Lifts Q4 Results
- Positive Sentiment: Strong cash generation and shareholder returns: record operating cash flow and ~$2.9B returned to shareholders in the year — supports buyback/dividend expectations and investor confidence. Colgate-Palmolive Company Announces 4th Quarter and Full Year 2025 Results
- Neutral Sentiment: Analysts and models are being updated after the print — some price‑target revisions were posted ahead/after the call; watch analyst notes for guidance sensitivity and margin assumptions. Colgate-Palmolive Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
- Negative Sentiment: Company recorded a large goodwill/intangible impairment tied to its skin‑health business that drove a GAAP loss for the quarter — this one‑time charge reduced headline EPS and highlights ongoing challenges in that segment. Colgate-Palmolive Swings to a Loss on Charges
- Negative Sentiment: Softer trends in China and margin pressure in parts of the portfolio were noted on the call — a reminder the recovery is uneven and could limit upside if those regions don’t stabilize. Colgate-Palmolive’s Core Strength Lifts Q4 Results
Colgate-Palmolive Profile
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
See Also
- Five stocks we like better than Colgate-Palmolive
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
